These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 31911674)
1. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Monaghan KG; Leach NT; Pekarek D; Prasad P; Rose NC; Genet Med; 2020 Apr; 22(4):675-680. PubMed ID: 31911674 [No Abstract] [Full Text] [Related]
2. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL; Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134 [No Abstract] [Full Text] [Related]
3. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL; Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068 [No Abstract] [Full Text] [Related]
4. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL; Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069 [No Abstract] [Full Text] [Related]
5. Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al. McGurk KA; Zheng SL; Henry A; Josephs K; Edwards M; de Marvao A; Whiffin N; Roberts A; Lumbers TR; O'Regan DP; Ware JS Genet Med; 2022 Mar; 24(3):744-746. PubMed ID: 34906520 [No Abstract] [Full Text] [Related]
6. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL; Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242 [TBL] [Abstract][Full Text] [Related]
7. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM; Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152 [TBL] [Abstract][Full Text] [Related]
8. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360 [TBL] [Abstract][Full Text] [Related]
9. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG). Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK; Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919 [No Abstract] [Full Text] [Related]
10. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG). Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL; Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974 [No Abstract] [Full Text] [Related]
11. Correspondence on "Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)" by Dungan et al. Prensky L; Persson F Genet Med; 2023 Sep; 25(9):100872. PubMed ID: 37266581 [No Abstract] [Full Text] [Related]
12. Clinical application of medical exome sequencing for prenatal diagnosis of fetal structural anomalies. Chen M; Chen J; Wang C; Chen F; Xie Y; Li Y; Li N; Wang J; Zhang VW; Chen D Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():119-124. PubMed ID: 32502767 [TBL] [Abstract][Full Text] [Related]
13. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA; Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417 [No Abstract] [Full Text] [Related]
14. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG). Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G; Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163 [No Abstract] [Full Text] [Related]
15. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454 [TBL] [Abstract][Full Text] [Related]
16. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG). Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S; Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921 [No Abstract] [Full Text] [Related]
17. Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG). ACMG Board of Directors Genet Med; 2021 Nov; 23(11):2027-2028. PubMed ID: 34183790 [No Abstract] [Full Text] [Related]
18. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M; Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144 [No Abstract] [Full Text] [Related]
19. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM; Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380 [TBL] [Abstract][Full Text] [Related]